ClinicalTrials.Veeva

Menu

Comparative Study Between Subcutaneous Tissue Closure Versus Drain in Obese Women Undergo Elective Cesarean Section

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Wound Infection

Treatments

Procedure: subcutanous sutures
Procedure: Cesarean section
Device: subcutanous drain

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Randomised cinical trial in Kasr Alainy Hospital.352 obese women pregnant with gestational age >38 wk ,theire age range from (25-35) years and BMI between (30 -40) undergoing elective cesarean section were randomised into 4 groups and compare the role of subcutaneous tissue closure in post cesarean section wound complications.

groups are: 4 groups each group was 86 women : A -interrupted closure of subcutaneous tissue with drain ( a closed nonvacuum drain was inserted in the tissue and exite from the skin through a separate opening and stitch to the skin) .

B-interrupted closure of subcutaneous tissue without drain. c- non closure of subcutaneous tissue with drain only. d- non closure of subcutaneous tissue without drain.

All womenu nder going CS with Pfannenstiel incision were considered to be eligible if time allowed informed consent before the surgery

Full description

Randomised cinical trial in Kasr Alainy Hospital.352 obese women pregnant with gestational age >38 wk ,their age range from (25-35) years and BMI between (30 -40) undergoing elective cesarean section were randomised into 3 groups (100 patients in each group)and compare the role of subcutaneous tissue closure in post cesarean section wound complications.

4 groups are:: A -interrupted closure of subcutaneous tissue with drain ( a closed nonvacuum drain was inserted in the tissue and exit from the skin through a separate opening and stitch to the skin) .

B-interrupted closure of subcutaneous tissue without drain. c- non closure of subcutaneous tissue with drain only. d- non closure of subcutaneous tissue without drain.

All women under going CS with Pfannenstiel incision were considered to be eligible if time allowed informed consent before the surgery All surgical procedures were performed by obstetric and gynecology residents under the supervision of attending physicians After the sequential closure of the uterus and peritoneum, the fascia was closed with 2-0 polyglactin 910 (Vicryl). The depth of the subcutaneous adipose tissue was measured with a sterile ruler from the fascia to the skin edge at the middle of the superior aspect of the skin incision.Women with a subcutaneous tissue thickness of 4.0 cm or more were then formally enrolled and randomized to one of the two subcutaneous closure techniques. Subcutaneous hemostasis were achieved using electrocautery and skin was approximated with subcuticular suture using 2-0 polyglactin910 (VicrylRapide).company city country In the drain group, a closed nonvacuum drain was inserted in the tissue and exite from the skin through a separate opening and stitch to the skin (Al Allair 2000). company city country The drain was left until the drainage rate was less than 30 ml/day or after 72h .( The skin was closed with a continuous nonabsorbable polypropylene 2/0 (Acufirm; Ernst Kratz, Germany) subcuticular sutures. Operative time was estimated from the start of skin incision until the end of skin suturing. The drain was left until the drainage rate was less than 50 ml/day.

All randomized women received standard postoperative wound care. Surgical dressing was removed on the first postoperative and all participants were discharged 24 h after the CS. The participants were invited to two follow-up in the first and second week post operative with regard to postoperative pain, postoperative fever, hospital stay duration, wound infection, wound seroma, wound disruption, and the need for redressing. The postoperative pain was judged after 24 h using visual analogue scale, in addition any time clinically indicated. Patients and physicians who assessed the incision postoperatively were blinded towards the study group.

Enrollment

352 patients

Sex

Female

Ages

25 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • obese women who BMI(30- 40 kg/m2)
  • Gestational age (37-41) week calculated by sure dates and confirmed by first trimester US,
  • single fetus.
  • Elective lower segment cesarean section

Exclusion criteria

  • Any medical disorders affect wound healing as:
  • Diabetes mellitus.
  • On steroids.
  • Immunedeficiency.
  • Hypoalbuminemia.
  • Skin infections or history of wound infections.
  • Multifetal pregnancy.
  • Obstetric complications eg.placenta previa.
  • Anemia.
  • Intraoperative complications as intestinal injury or bladder injury

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

352 participants in 4 patient groups

interrupted closure of subcutaneous tissue with drain
Active Comparator group
Description:
consist of 89 patients that will be allocated for interrupted closure of subcutaneous tissue with drain
Treatment:
Device: subcutanous drain
Procedure: Cesarean section
Procedure: subcutanous sutures
interrupted closure of subcutaneous tissue without dra
Active Comparator group
Description:
consist of 88 patients that will be allocated for interrupted closure of subcutaneous tissue without drain
Treatment:
Procedure: Cesarean section
Procedure: subcutanous sutures
non closure of subcutaneous tissue with drain
Active Comparator group
Description:
In the drain group,a closed non vacuum drain will be inserted in the tissue and exit from the skin through a separate opening and stitch to the skin
Treatment:
Device: subcutanous drain
Procedure: Cesarean section
non closure of subcutaneous tissue and no drain
Active Comparator group
Description:
87 women without subcutanous sutures and without drain
Treatment:
Procedure: Cesarean section

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems